Name: Quantification of Endothelial Fatty Acid Uptake using Fluorescent Fatty Acid Analogs (Video) | JoVE Journal
Uploaded: 2025-08-15T14:35:00.000+00:00
Duration: 6 min 3 s
Description: Learn to quantify endothelial fatty acid uptake using BODIPY fluorescent analogs in cultured cells. This in vitro assay enables precise measurement of lipid metabolism and reveals regulatory mechanisms relevant to metabolic disease research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

Tanisha Choudhury was funded by a Summer Undergraduate Research Fellowship from the Office for Undergraduate Research at the University of North Carolina at Chapel Hill. Boa Kim was supported by NHLBI (R56HL162660) and AHA (24CDA1264317). Ayon Ibrahim was supported by the Faculty Research Fund of Union College.

All human-derived endothelial cells (HUVECs) used in this study were obtained from commercially available, de-identified sources in accordance with institutional and vendor guidelines for ethical use of human biological materials. Perform all steps in a sterile environment under a laminar flow hood. See Table of Materials for a list of all reagents and equipment.
1. Gelatin coating of 96-well plate
<ol>
	<li>Prepare a 0.1% gelatin solution by diluting 25 mL of 2% gelatin stock in 500 mL 1x phosphate-buffered saline (PBS).</li>
	<li>Mix thoroughly and filter-sterilize using a 0.2 &#181;m vacuum filter (or autoclave).</li>
	<li>Add 100 &#181;L per well of the 0.1% gelatin to a black, clear-bottom 96-well plate.</li>
	<li>Incubate at 37 &#176;C for at least 30 min or ideally overnight.</li>
</ol>
2. Cell seeding
<ol>
	<li>Prepare a single-cell suspension of ECs in complete media.
	<ol>
		<li>Prepare complete media by supplementing the appropriate basal medium with 10% fetal bovine serum and 1% penicillin/streptomycin (v/v for both). 
		NOTE: Basal medium will differ based on the specific cell type; in this study, endothelial growth medium (EGM-2) and Dulbecco&#39;s modified Eagle&#39;s Medium (DMEM) were used for HUVECs and EA.hy926 cells, respectively.</li>
	</ol>
	</li>
	<li>Pipette 100 &#181;L of the cell suspension into each well at a seeding density that allows the cells to reach confluence by the next day.</li>
</ol>
3. Treatment reagent preparation and application
<ol>
	<li>Prepare all reagents in divalent PBS (with Ca2+ and Mg2+) and pre-warm to 37 &#176;C.
	<ol>
		<li>Prepare 3-HIB (positive control) as a 20 mM working solution. Dissolve the stock solution at 1 M in double-distilled water and store at 4 &#176;C.</li>
		<li>Prepare lactate (positive control) as a 20 mM working solution. Dissolve the stock solution at 1 M in double-distilled water and store at 4 &#176;C.</li>
		<li>Prepare niclosamide (negative control) at a final concentration of 1 &#181;M. Dissolve the stock solution at 10 mM in DMSO. Aliquot into smaller volumes to avoid freeze-thaw cycling, and store at -20 &#176;C.</li>
	</ol>
	</li>
	<li>Wash cells once with pre-warmed divalent PBS.</li>
	<li>Add 50 &#181;L per well of the appropriate treatment reagent (3-HIB, lactate, or niclosamide) and incubate at 37&#176; C for 30 min (for niclosamide) or 60 min (for 3-HIB and lactate).</li>
</ol>
4. BODIPY-FA: BSA complex preparation and application
<ol>
	<li>Prepare BODIPY-FA: BSA complexes at 0.5 &#181;M, 1 &#181;M, or 2 &#181;M final concentrations in PBS, using a 2:1 FA: BSA molar ratio. For a 2 &#181;M BODIPY-FA solution, incubate with 1 &#181;M FA-free BSA in PBS. For 1 &#181;M BODIPY-FA, use 0.5 &#181;M BSA, and so on. Always protect complexes from light during incubation.</li>
	<li>Incubate mixture at room temperature for 10 min before use.</li>
	<li>Add 50 &#181;L of the complex to treated wells. 
	NOTE: Use only the middle 10 columns to avoid edge effects. Reserve outer columns as autofluorescence controls, adding only PBS to these wells.</li>
	<li>Incubate the plate at 37 &#176;C for 1 min, 5 min, or 10 min.</li>
</ol>
5. Fluorescence quenching and intracellular signal detection
<ol>
	<li>Prepare 1 &#181;M FA-free BSA in PBS as a wash buffer and pre-warm to 37 &#176;C.</li>
	<li>Remove BODIPY-FA: BSA and wash the entire plate twice with 50 &#181;L of pre-warmed 1 &#181;M FA-free BSA in PBS. Perform each wash for 1.5 min.</li>
	<li>Add 50 &#181;L of 0.08% Trypan Blue to quench extracellular fluorescence.</li>
	<li>Immediately measure intracellular fluorescence using a microplate reader with the following settings: Excitation: 488 nm, Emission: 515 nm, Cutoff: 495 nm, Mode: Bottom-read. 
	NOTE: Subtract autofluorescence background using outer column wells containing cells that were not treated with BODIPY-FA in step 4.</li>
</ol>
6. Hoechst nuclear staining for cell normalization
<ol>
	<li>Remove Trypan Blue solution and gently wash with PBS. 
	NOTE: The cells may be somewhat fragile and prone to sloughing. Use caution when washing.</li>
	<li>Add 4 &#181;g/mL Hoechst in 10% media and incubate 30 min at 37 &#176;C. 
	NOTE: Hoechst incubation time may require optimization. Depending on the cell type, 5 min to 60 min may be needed to achieve uniform nuclear labeling and sufficient signal intensity. Do not add Hoechst to outer columns.</li>
	<li>Wash the plate once with PBS.</li>
	<li>Add fresh PBS and measure Hoechst fluorescence using the following settings: Excitation: 350 nm, Emission: 461 nm, Cutoff: 455 nm, Mode: Bottom-read. 
	NOTE: Subtract Hoechst autofluorescence background using outer column wells.</li>
	<li>Normalize BODIPY-FA fluorescence to cell number by dividing the autofluorescence-corrected values from step 5.3 by the corresponding Hoechst values obtained in step 6.4. Use background-corrected values for both BODIPY and Hoechst signals. 
	NOTE: The final values represent the BODIPY-FA uptake normalized to cell number, corrected for autofluorescence in both BODIPY and Hoechst channels.</li>
</ol>
7. Statistical analysis
<ol>
	<li>Perform statistical analysis for Figure 2 using two-way ANOVA to assess the effects of time, concentration, and their interaction. Apply Tukey&#39;s post hoc test for multiple comparisons.</li>
	<li>For Figure 3 and Figure 4, use Student&#39;s unpaired two-tailed t-test when comparing two conditions. For experiments involving three or more conditions, use one-way ANOVA followed by Dunnett&#39;s test for multiple comparisons.</li>
</ol>

<ol><li>Schwenk, R. W., Holloway, G. P., Luiken, J. J. F. P., Bonen, A., Glatz, J. F. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fatty+acid+transport+across+the+cell+membrane%3A+regulation+by+fatty+acid+transporters%5BTitle%5D)+AND+%22Prostaglandins+Leukot+Essent+Fatty+Acids%22%5BJournal%5D)">Fatty acid transport across the cell membrane: regulation by fatty acid transporters.</a> Prostaglandins Leukot Essent Fatty Acids. 82 (4-6), 149-154 (2010).</li>
<li>He, Q., Chen, Y., Wang, Z., He, H., Yu, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cellular+uptake%2C+metabolism+and+sensing+of+long-chain+fatty+acids%5BTitle%5D)+AND+%22Front+Biosci+%28Landmark+Ed%29%22%5BJournal%5D)">Cellular uptake, metabolism and sensing of long-chain fatty acids.</a> Front Biosci (Landmark Ed). 28 (1), 10(2023).</li>
<li>Mashek, D. G., Coleman, R. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cellular+fatty+acid+uptake%3A+the+contribution+of+metabolism%5BTitle%5D)+AND+%22Curr+Opin+Lipidol%22%5BJournal%5D)">Cellular fatty acid uptake: the contribution of metabolism.</a> Curr Opin Lipidol. 17 (3), 274-278 (2006).</li>
<li>Jang, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+branched-chain+amino+acid+metabolite+drives+vascular+fatty+acid+transport+and+causes+insulin+resistance%5BTitle%5D)+AND+%22Nat+Med%22%5BJournal%5D)">A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance.</a> Nat Med. 22 (4), 421-426 (2016).</li>
<li>Hagberg, C. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Vascular+endothelial+growth+factor+B+controls+endothelial+fatty+acid+uptake%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Vascular endothelial growth factor B controls endothelial fatty acid uptake.</a> Nature. 464 (7290), 917-921 (2010).</li>
<li>Hwangbo, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Endothelial+APLNR+regulates+tissue+fatty+acid+uptake+and+is+essential+for+apelin%27s+glucose-lowering+effects%5BTitle%5D)+AND+%22Sci+Transl+Med%22%5BJournal%5D)">Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects.</a> Sci Transl Med. 9 (407), eaad4000(2017).</li>
<li>Ibrahim, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Insulin-stimulated+adipocytes+secrete+lactate+to+promote+endothelial+fatty+acid+uptake+and+transport%5BTitle%5D)+AND+%22J+Cell+Sci%22%5BJournal%5D)">Insulin-stimulated adipocytes secrete lactate to promote endothelial fatty acid uptake and transport.</a> J Cell Sci. 135 (5), jcs258964(2022).</li>
<li>Kuo, A., Lee, M. Y., Sessa, W. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Lipid+droplet+biogenesis+and+function+in+the+endothelium%5BTitle%5D)+AND+%22Circ+Res%22%5BJournal%5D)">Lipid droplet biogenesis and function in the endothelium.</a> Circ Res. 120 (8), 1289-1297 (2017).</li>
<li>Ibrahim, A., Arany, Z. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Does+endothelium+buffer+fat%5BTitle%5D)+AND+%22Circ+Res%22%5BJournal%5D)">Does endothelium buffer fat.</a> Circ Res. 120 (8), 1219-1221 (2017).</li>
<li>Kim, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Endothelial+lipid+droplets+suppress+eNOS+to+link+high-fat+consumption+to+blood+pressure+elevation%5BTitle%5D)+AND+%22J+Clin+Invest%22%5BJournal%5D)">Endothelial lipid droplets suppress eNOS to link high-fat consumption to blood pressure elevation.</a> J Clin Invest. 133 (24), e173160(2023).</li>
<li>Dubikovskaya, E., Chudnovskiy, R., Karateev, G., Park, H. M., Stahl, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Measurement+of+long-chain+fatty+acid+uptake+into+adipocytes%5BTitle%5D)+AND+%22Methods+Enzymol%22%5BJournal%5D)">Measurement of long-chain fatty acid uptake into adipocytes.</a> Methods Enzymol. 538, 107-134 (2014).</li>
<li>Watkins, O. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Metabolism+of+13C-labeled+fatty+acids+in+term+human+placental+explants+by+liquid+chromatography-mass+spectrometry%5BTitle%5D)+AND+%22Endocrinology%22%5BJournal%5D)">Metabolism of 13C-labeled fatty acids in term human placental explants by liquid chromatography-mass spectrometry.</a> Endocrinology. 160 (6), 1394-1408 (2019).</li>
<li>Spangenburg, E. E., Pratt, S. J. P., Wohlers, L. M., Lovering, R. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Use+of+BODIPY+%28493%2F503%29+to+visualize+intramuscular+lipid+droplets+in+skeletal+muscle%5BTitle%5D)+AND+%22J+Biomed+Biotechnol%22%5BJournal%5D)">Use of BODIPY (493/503) to visualize intramuscular lipid droplets in skeletal muscle.</a> J Biomed Biotechnol. 2011, 598358(2011).</li>
<li>Fraser, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fatty+acid+uptake+in+diabetic+rat+adipocytes%5BTitle%5D)+AND+%22Mol+Cell+Biochem%22%5BJournal%5D)">Fatty acid uptake in diabetic rat adipocytes.</a> Mol Cell Biochem. 167 (1-2), 51-60 (1997).</li>
<li>Ibrahim, A., Yucel, N., Kim, B., Arany, Z. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Local+mitochondrial+ATP+production+regulates+endothelial+fatty+acid+uptake+and+transport%5BTitle%5D)+AND+%22Cell+Metab%22%5BJournal%5D)">Local mitochondrial ATP production regulates endothelial fatty acid uptake and transport.</a> Cell Metab. 32 (2), 309-319.e7 (2020).</li>
<li>Mehling, M., Tay, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Microfluidic+cell+culture%5BTitle%5D)+AND+%22Curr+Opin+Biotechnol%22%5BJournal%5D)">Microfluidic cell culture.</a> Curr Opin Biotechnol. 25, 95-102 (2014).</li>
<li>Zhao, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Organoids%5BTitle%5D)+AND+%22Nat+Rev+Methods+Primers%22%5BJournal%5D)">Organoids.</a> Nat Rev Methods Primers. 2 (1), 1-21 (2022).</li>
<li>Maiullari, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Modeling+breast+cancer+dynamics+through+modulable+small+vessel+environment+bioreactor+%28sVEB%29%5BTitle%5D)+AND+%22Biomaterials%22%5BJournal%5D)">Modeling breast cancer dynamics through modulable small vessel environment bioreactor (sVEB).</a> Biomaterials. 323, 123441(2025).</li>
<li>Murphy, A. R., Franco, R. A., Allenby, M. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fabricating+microfluidic+co-cultures+of+immortalized+cell+lines+uncovers+robust+design+principles+for+the+simultaneous+formation+of+patterned%2C+vascularized%2C+and+stem+cell-derived+adipose+tissue%5BTitle%5D)+AND+%22Small%22%5BJournal%5D)">Fabricating microfluidic co-cultures of immortalized cell lines uncovers robust design principles for the simultaneous formation of patterned, vascularized, and stem cell-derived adipose tissue.</a> Small. , e2501834(2025).</li>
</ol>

The authors have declared that no conflict of interest exists.

This assay offers a rapid, quantitative, and cost-effective method for measuring FA uptake in ECs using a 96-well plate-based format and fluorescent long-chain FA analogs. By incorporating both positive and negative controls and validating across primary (HUVECs) and immortalized (EA.hy926) ECs, this protocol demonstrates robustness, reproducibility, and broad applicability.
Fluorescence-based analyses have been instrumental in uncovering paracrine regulators of endothelial lipid transport, as mentioned earlier4,5,7. These examples highlight how a standardized system can continue to reliably elucidate metabolite-driven regulation of lipid transport in a controlled in vitro setting. The protocol described here establishes key parameters for reliable FA uptake measurements, including the use of BODIPY-C12 and BODIPY-C16 at multiple concentrations (0.5-2 &#181;M) and incubation times (1 min, 5 min, and 10 min). It also effectively detected increased uptake in response to 3-HIB and lactate, and reduced uptake following treatment with niclosamide, confirming both its sensitivity and dynamic range. While optimized here for ECs, this assay can be readily adapted to other cell types such as adipocytes, myotubes, or hepatocytes with adjustments to BODIPY: BSA ratios and treatment conditions. It can also be modified for live-cell imaging using compatible plates or adapted into a pulse-chase format to evaluate intracellular FA retention, metabolism, or efflux.
Compared to other approaches, this method offers distinct advantages: it is scalable, quantitative, and adaptable to various FA chain lengths. In addition, it is cost-effective, involves only a handful of steps, and requires instruments no more complex than a common microplate reader, allowing new users, including students, to quickly master this protocol. Finally, unlike qualitative microscopy-based methods or endpoint stains like Oil Red O, which reflect cumulative lipid content, this protocol captures real-time FA uptake without requiring fixation or lysis.
Nonetheless, several limitations should be noted. The use of a 2D static culture system does not fully recapitulate the physiological complexity of the vascular environment. Key factors such as shear stress or LPL-mediated lipolysis, as well as endothelial-parenchymal interactions, are absent from this simplified model. Advanced systems, such as microfluidic or organoid-based 3D co-cultures, better mimic in vivo architecture and signaling, though they do require greater technical expertise and infrastructure16,17. For example, microfluidic Bioreactors provide an environment in which ECs can mimic microvasculature formation and interact with other tissue types, allowing researchers to model paracrine dynamics in a more physiological setting18. Moreover, recent work has shown that specialized systems can be developed to carry out live fluorescent imaging in 3D hydrogel cultures19. Such advances provide confidence&#160;that this assay could one day be adapted to cell culture systems that are more physiologically representative, but optimization would need to be carried out.
In summary, this assay represents a flexible, accessible, and reproducible platform for investigating cellular FA uptake under diverse conditions. While best suited for mechanistic in vitro studies, insights gained from this system may inform future work using more physiologically relevant models of endothelial lipid transport.

In order for blood-borne nutrients such as lipids to get into metabolic tissue, such as skeletal muscle, they must first cross the endothelial cell (EC) barrier that comprises the walls of the capillary blood vessels. While it was long believed that fatty acids (FAs) simply diffused across this barrier to reach underlying tissue, emerging evidence suggests that ECs actively regulate this process through specialized transport mechanisms evolved to move hydrophobic molecules across aqueous extra- and intracellular worlds1.
In the bloodstream, FAs exist either as albumin-bound free fatty acids (FFAs) or are packaged within triglyceride-rich lipoproteins (TRLs) such as chylomicrons and very low-density lipoproteins (VLDLs)2. At the luminal surface of ECs, lipoprotein lipase (LPL) hydrolyzes TRLs to release FFAs for uptake. A variety of proteins are involved in FA transport, including CD36, which carries out the actual uptake of the FA into the cell; fatty acid transport proteins (FATPs) and acyl-CoA synthetases (ACSLs), which mediate vectorial transport; fatty binding proteins (FABPs), which act as lipophilic chaperones, and countless others, some still yet to be discovered and categorized2,3. The underlying tissue also uses similar mechanisms to take up the transported fat, though the specific isoforms present often differ based on cell type.
Recent studies have shown that ECs coordinate with neighboring cells through paracrine signaling to modulate FA transport into target tissues. For example, skeletal myocytes secrete a collection of paracrine factors like 3-hydroxyisobutyrate (3-HIB), vascular endothelial growth factor B (VEGFB), and apelin to promote FA transport by nearby endothelium4,5,6. Interestingly, the endocrine system may also be involved, as is the case when insulin stimulates adipocytes to release lactate, which also stimulates ECs to take up FAs7.
ECs thus act as modulatory gatekeepers of fat, suggesting they play a key role in lipid metabolic disorders such as cardiovascular disease or type 2 diabetes. Recent evidence has shown that the ECs themselves will accumulate lipid droplets (LDs) in response to fat overload, potentially acting as a buffer that regulates fatty acid delivery to underlying tissues8,9. In the case of high fat consumption, as is the case with modern diets, excessive accumulation of these LDs may contribute to vascular dysfunction and diseases, including hypertension10. Altogether, a better understanding of how ECs take up and transport FAs may provide us with new therapeutic handles for addressing lipid-borne diseases.
In this study, we describe a simple, rapid, and cost-effective assay for measuring endothelial FA uptake using fluorescent long-chain FA analogs BODIPY-C12 and BODIPY-C16. These reagents are fairly inexpensive and quite safe, especially compared to radioactive or heavy-isotope labeled FAs, which have been traditionally used to measure cellular fat uptake11,12. It is important to note that these reagents are distinct from the unconjugated &#8220;free&#8221; BODIPY dye, which passively accumulates in hydrophobic regions of the cell, mainly in LDs13. In contrast, conjugating BODIPY to an aliphatic FA chain (e.g., C12 or C16) produces a molecule that structurally mimics native long-chain FAs. This modification allows for the specific measurement of dynamic fatty acid uptake into cells, rather than reflecting intracellular lipid storage or droplet formation.&#160;&#160;&#160;&#160;
A key strength of this approach is its flexibility. Researchers can use other cell types, variable incubation times, and a range of BODIPY-conjugated FA analogs to study chain length-dependent uptake, or even naturally fluorescent lipids like cis-parinaric fatty acid14. Overall, this protocol will provide researchers with an easy way to test for cellular FA uptake under multiple conditions and pave the way for answering fundamental questions in lipid metabolism, endothelial biology, and metabolic disease (Figure 1).

<table><tbody><tr><td>3-Hydroxyisobutyrate (3-HIB)</td><td>Cayman Chemicals</td><td>26105</td><td>Positive control, 5 or 20 mM final concentration</td></tr><tr><td>96 well black, clear-bottom Polystyrene microplate</td><td>Sigma-Aldrich</td><td>CLS3603-48EA</td><td>For plating cells to be assayed</td></tr><tr><td>BODIPY FL C12 (Bodipy-FA)</td><td>Thermo Fisher Scientific</td><td>D3822</td><td>Green fluorescent long chain fatty acid</td></tr><tr><td>BODIPY FL C16 (Bodipy-FA)</td><td>Thermo Fisher Scientific</td><td>D3821</td><td>Green fluorescent very long chain fatty acid</td></tr><tr><td>Bovine Serum Albumin solution</td><td>Sigma-Aldrich</td><td>A9205-50ML</td><td>Used to prepare Bodipy:BSA complex</td></tr><tr><td>Dimethyl sulfoxide (DMSO)</td><td>Sigma-Aldrich</td><td>D2650</td><td>Solvent for drug stocks</td></tr><tr><td>Disposable Pipetting Reservoirs</td><td>VWR</td><td>89094-680</td><td>Contains the various solutions to be pipetted onto the cells</td></tr><tr><td>Dulbecco&amp;rsquo;s Modified Eagle&amp;rsquo;s Medium</td><td>Corning Life Sciences</td><td>10-013-CV</td><td>Media for EA.hy926 cells</td></tr><tr><td>EA.hy926 cells</td><td>ATCC</td><td>CRL-2922&amp;nbsp;</td><td>Immortalized endothelial cell hybrid line</td></tr><tr><td>EGM-2 Endothelial Cell Growth Medium-2 BulletKit</td><td>Lonza</td><td>CC-3162</td><td>Media for HUVECs</td></tr><tr><td>Fetal Bovine Serum (FBS)&amp;nbsp;</td><td>VWR</td><td>97068-085</td><td>10% supplement in EGM-2 and DMEM</td></tr><tr><td>Fluorescence microplate reader</td><td>Various</td><td>N/A</td><td>Any microplate reader capable of flourescence measurements</td></tr><tr><td>Gelatin solution</td><td>Sigma-Aldrich</td><td>G1393-100ml</td><td>Used to coat plates at 0.1% working concentration</td></tr><tr><td>Hoechst 33342 Solution</td><td>Life Science</td><td>62249</td><td>Nuclear stain for cell normalization (4 &amp;mu;M)</td></tr><tr><td>Human umbilical vein endothelial cells (HUVECs)</td><td>Lonza</td><td>C2519A</td><td>Primary human endothelial cells</td></tr><tr><td>Multichannel Pipette</td><td>VWR</td><td>76627-768</td><td>For pipetting into a 96-well plate</td></tr><tr><td>Niclosamide&amp;nbsp;</td><td>Millipore Sigma</td><td>N3510-50G</td><td>Negative control, 1 &amp;mu;M&amp;nbsp; final concentration</td></tr><tr><td>PBS, with calcium and magnesium</td><td>Fisher Scientific</td><td>21031CV</td><td>Used for preparing treatments and as a wash buffer (with BSA)</td></tr><tr><td>PBS, without calcium and magnesium</td><td>Genesee Scientific</td><td>25-508</td><td>For gelatin dilution, Hoechst staining, and general washes</td></tr><tr><td>Penicillin/Streptomycin</td><td>Thermo Fisher Scientific</td><td>15140122</td><td>1% supplement in EGM-2 and DMEM</td></tr><tr><td>Sodium L-lactate</td><td>Sigma-Aldrich</td><td>L7022-5G</td><td>Positive control, 5 or 20 mM final concentration</td></tr><tr><td>Trypan Blue solution</td><td>Sigma-Aldrich</td><td>T8154-20ML</td><td>Used at 0.08% to quench extracellular fluorescence</td></tr><tr><td>Vacuum Filter Systems, 500ml PES Membrane, 0.45&amp;micro;m</td><td>GenClone</td><td>25-227</td><td>To sterilize gelatin solution</td></tr></tbody></table>

quantification of endothelial fatty acid uptake using fluorescent fatty acid analogs

Quantification of Endothelial Fatty Acid Uptake using Fluorescent Fatty Acid Analogs

Endothelial cells (ECs) play a central role in regulating fatty acid (FA) transport from the bloodstream into metabolic tissues, yet tools to quantify EC FA uptake in a reliable, scalable manner remain limited. Here, we present a rapid, quantitative, and cost-effective assay to measure FA uptake in ECs using fluorescent FA analogs (BODIPY-C12 and BODIPY-C16), which allow investigation of chain length-specific uptake dynamics in a 96-well plate format. The protocol incorporates positive (3-hydroxyisobutyrate, lactate) and negative (niclosamide) controls and is validated in both primary (HUVECs) and immortalized (EA.hy926) EC lines. The assay detects time- and dose-dependent FA uptake, with results normalized to cell number using Hoechst nuclear staining and corrected for background using appropriate controls. It can be adapted to a variety of cell types, imaging modalities, and experimental conditions, including live-cell imaging and pulse-chase formats. Compared to traditional lipid staining or radiolabeled tracers, this method offers improved safety, speed, and versatility while capturing dynamic FA uptake in live cells. This assay provides a robust platform for studying the regulation of endothelial lipid transport and its contribution to metabolic disease.

As illustrated in Figure 1, this assay uses a 96-well plate format where ECs are seeded directly into wells. BODIPY-labeled FAs are conjugated to bovine serum albumin (BSA) and applied to both experimental and control wells. Prior to FA treatment, ECs can be manipulated through pharmacological treatments or genetic perturbations such as siRNA transfection or CRISPR gene editing. Crucially, such manipulations also allow for the inclusion of appropriate positive and negative controls to ensure assay reliability.
A clear dose- and time-dependent increase in intracellular BODIPY-C12 signal was observed after incubating BODIPY-C12 at 0.5 µM, 1 µM, and 2 µM for 1 min, 5 min, and 10 min in both HUVECs and EA.hy926 cells (Figure 2). To account for potential variations in cell number per well, BODIPY-C12 values were normalized to Hoechst nuclear staining and measured fluorescently. Background autofluorescence was corrected using no-BODIPY and no-Hoechst control wells.
To validate assay reproducibility and range, known modulators of fatty acid metabolism were tested in EA.hy926 ECs using BODIPY-C12 (Figure 3). 1-h treatment with increasing concentrations of lactate (0 mM, 5 mM, 20 mM) or 3-HIB (0 mM, 5 mM, 20 mM) enhanced BODIPY-C12 uptake in a dose-dependent manner, confirming their roles as positive regulators of FA uptake. Conversely, it has been previously demonstrated that the chemical niclosamide can inhibit fatty acid uptake via mitochondrial uncoupling15. Indeed, similar results were reproduced here, as 30 min of treatment with niclosamide (1 µM) significantly reduced BODIPY-C12 signal relative to vehicle control, validating its utility as a negative control. While these data are normalized to Hoechst to account for any differences in cell number, none of these treatments altered cell viability or Hoechst fluorescence values.
In order to assess the assay's adaptability to different fatty acid analogs, BODIPY-C16, which can be considered a proxy for a very long-chain fatty acid, was given to HUVECs, and its uptake was measured following 5-min incubations (Figure 4). It was observed that lactate treatment (0 mM, 10 mM, 20 mM) increased BODIPY-C16 signal in a dose-dependent manner, while niclosamide (1 µM) reduced the signal, mirroring results observed with BODIPY-C12.
All in all, this assay has enabled robust and reproducible quantification of FA uptake in both primary (HUVEC) and immortalized (EA.hy926) ECs. Furthermore, these findings demonstrate the versatility of the assay across FAs of varying chain lengths, as well as showcasing the validity of both positive and negative controls.
<img alt="BODIPY-FA experiment in 96-well plate; fluorescence measurement; cell treatment timeline diagram." class="xfigimg" src="/files/ftp_upload/68859/68859fig1.jpg" data-altupdatedat="1783396841000" data-alt="Figure 1"> 
Figure 1: Schematic of the fatty acid uptake assay using BODIPY-labeled fatty acids. Endothelialcells are seeded into a black, clear-bottom 96-well plate and incubated with BODIPY-conjugated fatty acid (FA) analogs to enable intracellular uptake. Following incubation, extracellular fluorescence is quenched with Trypan Blue, and intracellular signal is measured using a bottom-read fluorescence microplate reader. Hoechst nuclear stain is applied after fluorescence measurement to quantify cell number for normalization. Pharmacological treatment or genetic perturbations can be applied prior to BODIPY-FA incubation. <a href="https://www.jove.com/files/ftp_upload/68859/68859fig1large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Bodipy-FA incubation results, HUVEC vs. EA.hy926, fluorescence intensity bar graph analysis." class="xfigimg" src="/files/ftp_upload/68859/68859fig2.jpg" data-altupdatedat="1783396841000" data-alt="Figure 2"> 
Figure 2: Quantification of BODIPY-C12 uptake in primary and immortalized endothelial cells. (A) Time- and concentration-dependent increase in BODIPY-C12 uptake in HUVECs following 1 min, 5 min, and 10 min incubations at 0.5 µM, 1 µM, and 2 µM BODIPY-C12 complexed to 0.25 µM, 0.5 µM, and 1 µM FA-free BSA, respectively. (B) EA.hy926 cells exhibited similar time- and dose-dependent BODIPY-C12 uptake under identical conditions. Mean fluorescence intensity was normalized to Hoechst-stained nuclei (cell number) and no-BODIPY controls. Data are shown as mean ± SD. Statistical analysis was performed using two-way ANOVA to assess the effects of time, concentration, and their interaction, followed by Tukey's post hoc test for multiple comparisons. Significant main effects were observed for time (p &lt; 0.0001), concentration (p &lt; 0.0001), and their interaction (p = 0.0443). Statistically significant pairwise comparisons identified by Tukey's test are indicated on the bar graph as follows: *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, and ****p &lt; 0.0001. <a href="https://www.jove.com/files/ftp_upload/68859/68859fig2large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Lipid uptake assay results; graphs showing Bodipy-C₁₂ quantification under lactate, 3-HIB, niclosamide." class="xfigimg" src="/files/ftp_upload/68859/68859fig3.jpg" data-altupdatedat="1783396841000" data-alt="Figure 3"> 
Figure 3: Validation of the assay using positive and negative controls in EA.hy926. (A) 1-h lactate treatment (0 mM, 5 mM, 20 mM) increased BODIPY-C12 uptake in a dose-dependent manner. (B) 1-h 3-HIB treatment (0 mM, 5 mM, 20 mM) similarly increased FA uptake. (C) 30-min Niclosamide treatment (1 µM) significantly suppressed BODIPY-C12 uptake relative to vehicle control (DMSO). Mean fluorescence intensity was normalized to Hoechst-stained nuclei (cell number) and no-BODIPY controls. Data are shown as mean ± SD. 2 µM BODIPY-C12 (complexed to 1 µM fatty acid-free BSA) was incubated for 5 min for all experiments. Statistics for (A) and (B) were determined using one-way ANOVA with Dunnett's test for multiple comparisons, and for C using Student's unpaired two-tailed T test. ****p &lt; 0.0001. <a href="https://www.jove.com/files/ftp_upload/68859/68859fig3large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Bar chart comparing Bodipy-C16/Hoechst ratio with lactate and niclosamide treatment results." class="xfigimg" src="/files/ftp_upload/68859/68859fig4.jpg" data-altupdatedat="1783396841000" data-alt="Figure 4"> 
Figure 4: Assay validation using BODIPY-C16 in HUVECs. (A) Lactate treatment (0 mM, 10 mM, 20 mM for 1 h) enhanced BODIPY-C16 uptake in a dose-dependent manner. (B) Niclosamide treatment (1 µM for 1 h) significantly reduced the BODIPY-C16 signal compared to vehicle-treated control. Mean fluorescence intensity was normalized to Hoechst-stained nuclei (cell number) and no-BODIPY controls. Data are shown as mean ± SD. 2 µM BODIPY-C16 (complexed to 1 µM fatty acid-free BSA) was incubated for 5 min for all experiments. Statistics for (A) were determined using one-way ANOVA with Dunnett's test for multiple comparisons, and for B using Student's unpaired two-tailed T test. *p &lt; 0.05, ***p &lt; 0.001, and ****p &lt; 0.0001. <a href="https://www.jove.com/files/ftp_upload/68859/68859fig4large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>

This protocol details an in vitro assay for measuring cellular lipid uptake in endothelial cells upon stimulation with BODIPY-C12 and BODIPY-C16 fluorescent analogs of long-chain and very long-chain saturated fatty acids. This method is efficient and adaptable to other cell types, offering a useful approach for studying lipid metabolism.

Endothelial cells (ECs) play a central role in regulating fatty acid (FA) transport from the bloodstream into metabolic tissues, yet tools to quantify EC ...

Bloodborne nutrients, like fatty acids, must cross a capillary endothelial barrier to enter metabolic tissue via a poorly understood mechanisms. Clarifying these processes could reveal new therapeutic targets for treating metabolic diseases, such as type 2 diabetes. So we found that scalpel muscle and adipose tissue both regulate endothelial lipid uptake and transport using paracrine metabolites, partly controlled by the endocrine system as well.And we've also found that mitochondrial ATP unexpectedly contribute to endothelial fat uptake despite their known reliance on glycolytic ATP. Using the assay outlined in this protocol, we plan to probe deeper into the molecular mechanisms underlying endothelial fatty acid uptake and transport, including how it might be regulated by other tissue. To begin, prepare a 0.1%gelatin solution by adding 25 milliliters of 2%gelatin stock to 475 milliliters of PBS.Mix the gelatin solution thoroughly and filter sterilize it using a 0.2 micrometer vacuum filter or autoclave. Using a pipette, add 100 microliters of the 0.1%gelatin solution into each well of a black clear bottom 96-well plate. Place the plate in a 37 degree Celsius incubator for at least 30 minutes or overnight.After incubation, remove extra gelatin solution from the pre-coated 96-well plate. Wash the plate with PBS once. Then, pipette 100 microliters of the cell suspension into each well using a seeding density that allows the cells to reach confluence by the next day.Prepare 20 millimolar solutions of 3-hydroxyisobutyrate and lactate as positive controls. For the negative control, use one micromolar niclosamide. Then, pipette the solutions into a separate 96-well plate.Wash the endothelial cells once with pre-warmed divalent PBS, pipetting at a steep angle to avoid disrupting the plated cells. Add 50 microliters per well of the appropriate treatment reagent and incubate the plate at 37 degrees Celsius for 30 minutes or 60 minutes. To prepare the BODIPY fatty acid BSA complex, mix a 2 micromolar BODIPY fatty acid solution with 1 micromolar fatty acid-free BSA in PBS.Incubate the mixture at room temperature in the dark for 10 minutes before use. Next, add 50 microliters of the prepared BODIPY fatty acid BSA complex to each treated well and incubate the plate at 37 degrees Celsius for five minutes. Prepare a 1 micromolar solution of fatty acid-free BSA in PBS as a wash buffer and pre-warm it to 37 degrees Celsius.Remove the BODIPY fatty acid BSA complex from the wells and wash the entire plate twice with 50 microliters of the pre-warmed wash buffer, performing each wash for 1.5 minutes. Then, add 50 microliters of 0.08%trypan blue to each well to quench extracellular fluorescence. Using a microplate reader, immediately measure intracellular fluorescence.After removing the trypan blue solution from the wells, gently wash the cells with PBS. Add 4 micrograms per milliliter of Hoechst dye diluted in 10%media to each well. Incubate the plate at 37 degrees Celsius for 30 minutes.Then, wash the plate once with PBS to remove excess dye. After that, add fresh PBS to each well and measure Hoechst fluorescence using a microplate reader. In both HUVEC and EA.hy926 cells, intracellular BODIPY-C12 signal increased significantly with higher BODIPY fatty acid concentrations at one minute, five minutes and 10 minutes of incubation.Lactate treatment for one hour increased BODIPY-C12 uptake in a dose-dependent manner at 5 millimolar and 20 millimolar concentrations. Treatment with 3-hydroxyisobutyrate also significantly enhanced BODIPY-C12 uptake in a dose-dependent fashion with the highest uptake observed at 20 millimolar. Treatment with 1 micromolar niclosamide for 30 minutes led to a significant reduction in BODIPY-C12 uptake compared to untreated DMSO control.Following five minute incubation with BODIPY-C16 in HUVEC, lactate treatment at 10 millimolar and 20 millimolar significantly increased uptake in a dose-dependent manner. Treatment with 1 micromolar niclosamide significantly decreased BODIPY-C16 uptake compared to the untreated DMSO control.

quantification-endothelial-fatty-acid-uptake-using-fluorescent-fatty

Research

JoVE Journal

Biology

In this video, we demonstrate an ex vivo technique to measure extracellular glucose analog depletion in harvested mouse organs. It involves incubating the mouse tissue in a solution containing fluorescently-labeled deoxyglucose, which is taken up by the cells. The glucose analog uptake can be indirectly determined by measuring the fluorescence of the incubated medium.

Measurement of Extracellular Fluorescent Glucose Analog Depletion: A Surrogate Measurement Technique to Assess Glucose Uptake in Mouse Organs Ex Vivo

We report an in vitro method that allows the quantitation of the actual number of adhesive cells within an endothelial cell monolayer.

Quantitation of Endothelial Cell Adhesiveness In Vitro

We provide a detailed protocol to study bile acid dynamics in living cells using a genetically encoded BAS FRET sensor. This Bile Acid Sensor represents a unique tool to study (regulation of) bile acid transport and FXR activation in a wide range of cell types.

Real Time Monitoring of Intracellular Bile Acid Dynamics Using a Genetically Encoded FRET-based Bile Acid Sensor

Primary human umbilical vein endothelial cells (HUVECs) were grown to confluence within a microfluidic network device. The endothelial cell junction and F-actin distributions were illustrated and the changes in intracellular calcium concentration and nitric oxide production in response to adenosine triphosphate (ATP) were quantified in real-time at individual cell levels.

Development and Characterization of In Vitro Microvessel Network and Quantitative Measurements of Endothelial [Ca2+]i and Nitric Oxide Production

Vascular endothelium tightly controls leukocyte recruitment. Inadequate leukocyte extravasation contributes to human inflammatory diseases. Therefore, searching for novel regulatory elements of endothelial activation is necessary to design improved therapies for inflammatory disorders. Here, we describe a comprehensive methodology to characterize novel endothelial regulators that can modify leukocyte trafficking during inflammation.

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Traditional methods of assessing adipogenic differentiation are cheap and easy to use, but are not specific to changes in gene expression. We have developed an assay to quantify mesenchymal cell differentiation into mature adipocytes using a lineage specific marker. This assay has diverse applications across basic research and clinical medicine.

Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker

This protocol provides an efficient approach to measuring LDL cholesterol uptake with real time influx rates using a live cell imaging system in various cell types. This technique provides a platform to screen the pharmacological activity of compounds affecting LDL influx while monitoring for cell morphology and hence potential cytotoxicity.

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Measurement of in vitro cholesterol efflux capacity to serum or plasma in macrophage cell models is a promising tool as a biomarker for atherosclerosis. In the present study, we optimize and standardize a fluorescent NBD-cholesterol efflux method and develop a high-throughput analysis using 96-well plates.

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Automated assays using multi-well microplates are advantageous approaches for identifying pathway regulators by allowing the assessment of a multitude of conditions in a single experiment. Here, we have adapted the well-established macropinosome imaging and quantification protocol to a 96-well microplate format and provide a comprehensive outline for automation using a multi-mode plate reader.

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes

Herein, we demonstrate an optimized BODIPY 493/503 fluorescence-based protocol for lipid droplet characterization in liver tissue. Through the use of orthogonal projections and 3D reconstructions, the fluorophore allows for successful discrimination between microvesicular and macrovesicular steatosis and may represent a complementary approach to the classical histological protocols for hepatic steatosis assessment.

Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Learn to quantify endothelial fatty acid uptake using BODIPY fluorescent analogs in cultured cells. This in vitro assay enables precise measurement of lipid metabolism and reveals regulatory mechanisms relevant to metabolic disease research.

Quantification of Endothelial Fatty Acid Uptake using Fluorescent Fatty Acid Analogs

Explore More Videos